Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

The Pharmaceutical Market: Zambia, Market Research and Growth Report

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales.
MarketsandMarkets™ | 06.04.2016

The Pharmaceutical Market: Zambia Size and Share Published in 2014-11-28 Available for US$ 1295 at Researchmoz.us

Description

OVERVIEW OF THE PHARMACEUTICAL MARKET IN ZAMBIA


The majority of investment in Zambia's healthcare market stems from international aid agencies - so the news that the government has increased its allocation for healthcare spending in the 2013 budget will be well received by both NGOs and international investors as a sign that Zambia is taking its commitment to healthcare seriously. The country suffers from a burden of both communicable and non-communicable diseases, with a high incidence of HIV and AIDs, malaria, and problems such as cholera emerging in Q4 12, but it is making progress. The government claims it has already met its millennium development goals for turbercolosis, and is on target to meet other healthcare goals. Risks remain, such as the presence of counterfeit and substandard drugs, and the reliance on copper export means Zambia's economy has a narrow base.

Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=240630

Headline Expenditure Projections

Pharmaceuticals: ZMK951bn (US$196mn) in 2011 to ZMK1,095bn (US$207mn) in 2012; +15.1% in local currency terms and +5.7% in US dollar terms. Forecast lowered slightly from Q4 12.

Healthcare: ZMK5,347bn (US$1.10bn) in 2011 to ZMK6,290bn (US$1.19bn) in 2012; +17.6% in local currency terms and +8.0% in US dollar terms. Forecast lowered slightly from Q4 12.

Risk/RewardRating

In Q1 13, Zambia remained steady at 21st best market in the MEA region in BMI's proprietary Risk/Reward Ratings (RRR) matrix with a score of 39.6.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=240630

Table of Content


BMI Industry View7

SWOT9

Political10

Economic11

Business Environment13

Industry Forecast15

Pharmaceutical Market Forecast15

Table: Pharmaceutical Sales, Historical Data And Forecasts (Zambia 2010-2018)16

Healthcare Market Forecast17

Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Zambia 2010-2018)20

Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Zambia 2010-2018)21

Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Zambia 2010-2018)22

Macroeconomic Forecasts23

Table: GDP By Expenditure (Zambia 2011-2018)26

Industry Risk Reward Ratings27

Middle East & Africa Risk/Reward Ratings27

Zambia Risk/Reward Ratings34

Rewards34

Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html

About ResearchMoz


ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/

For More Report Click Here @ http://www.prweb.com/search.aspx?search-releases=researchmoz&hitsPerPage=20





Img of MarketsandMarkets™
About the tenderer: MarketsandMarkets™

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports.